Back

Hemodynamic changes in response to SGLT2 inhibitor treatment in ICD and CRT patients: insights from HeartLogic sensor data

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure management: cardiac resynchronisation therapy and guideline-directed medical therapy synergy Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Frederik Holme Fussing

Gentofte University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
The shorter the better? clinical outcomes of CRT-P/D-patients with a focus on stimulated QRS duration.
Doctor R. Larbig (Moenchengladbach, DE)
Abstract Slides
Presentation thumbnail
Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after non-cardiac surgery
Doctor K. Durak (Basel, CH)
Abstract Slides
Presentation thumbnail
Medication non-adherence assessed using liquid chromatography tandem mass spectrometry in ambulatory patients with heart failure referred for device therapy assessment
Doctor S. Sze (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Optimisation of guideline-directed medical therapy following cardiac resynchronization therapy in patients with heart failure
Doctor M. Montella (Monza, IT)
Abstract Slides
Presentation thumbnail
Patterns of medication use among patients hospitalized for heart failure
Ms S. Matseyko (DE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure management: cardiac resynchronisation therapy and guideline-directed medical therapy synergy

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of sacubitril/valsartan and SGLT2 inhibitors on echocardiographic response and clinical outcomes after cardiac resynchronization therapy: insights from a real-world cohort
28 August 2026
thumbnail
Congress Presentation
Incidence of erythrocytosis and thromboembolic risk in patients with heart failure and reduced ejection fraction treated with SGLT2 Inhibitors
17 May 2025
thumbnail
Congress Presentation
Precision therapeutics in heart failure: continuous cardiac device data detect early response to sacubitril/valsartan
28 August 2026
thumbnail
Congress Presentation
Effects of SGLT-2 inhibitors on myocardial work in patients with heart failure with reduced ejection fraction
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources